Title: In vitro and in vivo activities of the novel anticytomegalovirus compound AIC246.
Journal: Antimicrobial agents and chemotherapy 20100301
Title: The non-nucleoside antiviral, BAY 38-4766, protects against cytomegalovirus (CMV) disease and mortality in immunocompromised guinea pigs.
Journal: Antiviral research 20050101
Title: Antiviral therapies.
Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20040401
Title: Interactions among antiviral drugs acting late in the replication cycle of human cytomegalovirus.
Journal: Antiviral research 20021001
Title: [Drugs against human cytomegalovirus].
Journal: Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20020901
Title: Focus on new drugs in development against human cytomegalovirus.
Journal: Drugs 20020101
Title: Novel non-nucleoside inhibitors of cytomegaloviruses (BAY 38-4766): in vitro and in vivo antiviral activity and mechanism of action.
Journal: The Journal of antimicrobial chemotherapy 20011201
Title: A novel nonnucleoside inhibitor specifically targets cytomegalovirus DNA maturation via the UL89 and UL56 gene products.
Journal: Journal of virology 20011001
Title: Susceptibilities of human cytomegalovirus clinical isolates to BAY38-4766, BAY43-9695, and ganciclovir.
Journal: Antimicrobial agents and chemotherapy 20011001
Title: Inhibition of murine cytomegalovirus and human cytomegalovirus by a novel non-nucleosidic compound in vivo.
Journal: Antiviral research 20010301
Title: Weber O, et al. Inhibition of murine cytomegalovirus and human cytomegalovirus by a novel non-nucleosidic compound in vivo. Antiviral Res. 2001 Mar;49(3):179-89.
Title: Reefschlaeger J, et al. Novel non-nucleoside inhibitors of cytomegaloviruses (BAY 38-4766): in vitro and in vivo antiviral activity and mechanism of action. J Antimicrob Chemother. 2001 Dec;48(6):757-67.
